|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
110.25(B) |
Last
Volume: |
6,013,077 |
Avg
Vol: |
8,376,873 |
52
Week Range: |
$48.64 - $77.42 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
304,513 |
503,645 |
996,293 |
2,118,674 |
Total Sell Value |
$22,679,618 |
$34,760,114 |
$60,765,476 |
$110,963,213 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
26 |
43 |
79 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Colen Fred |
EVP & Chief Technology Officer |
|
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
65,827 |
|
- |
|
Capello Jeffrey D |
SVP, Chief Accounting Officer |
|
2010-02-24 |
4 |
D |
$7.80 |
$8,923 |
D/D |
(1,144) |
21,882 |
|
- |
|
Capello Jeffrey D |
SVP, Chief Accounting Officer |
|
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
23,026 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, Endovascular |
|
2010-02-24 |
4 |
D |
$7.80 |
$4,025 |
D/D |
(516) |
33,059 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, Endovascular |
|
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,326 |
33,575 |
|
- |
|
Leno Sam R |
CFO & EVP Finance & IS |
|
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,024 |
233,488 |
|
- |
|
Kucheman William |
EVP, Cardiology |
|
2010-02-24 |
4 |
D |
$7.80 |
$7,465 |
D/D |
(957) |
44,421 |
|
- |
|
Kucheman William |
EVP, Cardiology |
|
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
45,378 |
|
- |
|
Burns Brian R |
SVP - Global Quality |
|
2010-02-24 |
4 |
D |
$7.80 |
$8,954 |
D/D |
(1,148) |
39,433 |
|
- |
|
Burns Brian R |
SVP - Global Quality |
|
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,615 |
40,581 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, Endovascular |
|
2010-02-16 |
4 |
D |
$7.41 |
$8,418 |
D/D |
(1,136) |
32,249 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, Endovascular |
|
2010-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,920 |
33,385 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-02-16 |
4 |
D |
$7.41 |
$5,202 |
D/D |
(702) |
22,876 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,635 |
23,578 |
|
- |
|
Phalen Michael P. |
SVP & President, Endoscopy |
|
2010-02-12 |
4 |
D |
$7.39 |
$9,186 |
D/D |
(1,243) |
21,343 |
|
- |
|
Phalen Michael P. |
SVP & President, Endoscopy |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,274 |
22,586 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-02-12 |
4 |
D |
$7.39 |
$12,659 |
D/D |
(1,713) |
21,943 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
23,656 |
|
- |
|
Pedersen John B. |
Pres,Uro & Womens Health |
|
2010-02-12 |
4 |
D |
$7.39 |
$2,801 |
D/D |
(379) |
619 |
|
- |
|
Pedersen John B. |
Pres,Uro & Womens Health |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
998 |
998 |
|
- |
|
Leno Sam R |
CFO & EVP Finance & IS |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,982 |
227,464 |
|
- |
|
Burns Brian R |
SVP - Global Quality |
|
2010-02-12 |
4 |
D |
$7.39 |
$25,362 |
D/D |
(3,432) |
37,700 |
|
- |
|
Burns Brian R |
SVP - Global Quality |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,806 |
41,132 |
|
- |
|
Paul Donovan |
SVP, Corporate Communications |
|
2010-02-12 |
4 |
D |
$7.39 |
$24,424 |
D/D |
(3,305) |
33,103 |
|
- |
|
Paul Donovan |
SVP, Corporate Communications |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,406 |
36,408 |
|
- |
|
2009 Records found
|
|
Page 53 of 81 |
|
|